Post-Market Clinical Follow-Up Study on the Safety and Performance of Ennovate® Cervical
Multicenter Post-Market Clinical Follow-Up Study on the Safety and Performance of Ennovate® Cervical - a Prospective Study on Total Indications
Aesculap AG
200 participants
Jul 21, 2021
OBSERVATIONAL
Conditions
Summary
Multicenter Post market clinical follow-up Study on the Safety and Performance of Ennovate® Cervical - Prospective, pure data collection of all Ennovate Cervical patients in Total Indications
Eligibility
Inclusion Criteria4
- Patient is minimum 18 years old
- Informed Consent in the documentation of clinical and radiological results
- Patient has indication according to Instructions for Use (IFU)
- Patient is not pregnant
Exclusion Criteria1
- Patient's clear unability or unwillingness to participate in follow-up examinations
Interventions
The Ennovate® Cervical Spinal System is a posterior stabilization for the cervical and upper-thoracic spine. The implants are used for the posterior monosegmental and multisegmental stabilization of the occipitocervical junction and of the cervical and upper thoracic spine.
Locations(4)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05296889